Global Anticancer Drug Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Anticancer Drug Revenue
• 1.4 Market by Type
  • 1.4.1 Global Anticancer Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Targeted Drugs
  • 1.4.3 Cytotoxic Drugs
  • 1.4.4 Hormonal Drugs
• 1.5 Market by Application
  • 1.5.1 Global Anticancer Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Immunotherapy
  • 1.5.3 Targeted Therapy
  • 1.5.4 Chemotherapy
  • 1.5.5 Hormonal Therapy
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Anticancer Drug Market Perspective (2015-2026)
• 2.2 Global Anticancer Drug Growth Trends by Regions
  • 2.2.1 Anticancer Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Anticancer Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Anticancer Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Anticancer Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Anticancer Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Anticancer Drug Players by Market Size
  • 3.1.1 Global Top Anticancer Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Anticancer Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Anticancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Anticancer Drug Market Concentration Ratio
  • 3.2.1 Global Anticancer Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Anticancer Drug Revenue in 2019
• 3.3 Anticancer Drug Key Players Head office and Area Served
• 3.4 Key Players Anticancer Drug Product Solution and Service
• 3.5 Date of Enter into Anticancer Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Anticancer Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Anticancer Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Anticancer Drug Market Size by Application (2015-2020)
• 5.2 Global Anticancer Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Anticancer Drug Market Size (2015-2020)
• 6.2 Anticancer Drug Key Players in North America (2019-2020)
• 6.3 North America Anticancer Drug Market Size by Type (2015-2020)
• 6.4 North America Anticancer Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Anticancer Drug Market Size (2015-2020)
• 7.2 Anticancer Drug Key Players in Europe (2019-2020)
• 7.3 Europe Anticancer Drug Market Size by Type (2015-2020)
• 7.4 Europe Anticancer Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Anticancer Drug Market Size (2015-2020)
• 8.2 Anticancer Drug Key Players in China (2019-2020)
• 8.3 China Anticancer Drug Market Size by Type (2015-2020)
• 8.4 China Anticancer Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Anticancer Drug Market Size (2015-2020)
• 9.2 Anticancer Drug Key Players in Japan (2019-2020)
• 9.3 Japan Anticancer Drug Market Size by Type (2015-2020)
• 9.4 Japan Anticancer Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Anticancer Drug Market Size (2015-2020)
• 10.2 Anticancer Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Anticancer Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Anticancer Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Anticancer Drug Market Size (2015-2020)
• 11.2 Anticancer Drug Key Players in India (2019-2020)
• 11.3 India Anticancer Drug Market Size by Type (2015-2020)
• 11.4 India Anticancer Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Anticancer Drug Market Size (2015-2020)
• 12.2 Anticancer Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Anticancer Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Anticancer Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Roche
  • 13.1.1 Roche Company Details
  • 13.1.2 Roche Business Overview
  • 13.1.3 Roche Anticancer Drug Introduction
  • 13.1.4 Roche Revenue in Anticancer Drug Business (2015-2020))
  • 13.1.5 Roche Recent Development
• 13.2 Celgene
  • 13.2.1 Celgene Company Details
  • 13.2.2 Celgene Business Overview
  • 13.2.3 Celgene Anticancer Drug Introduction
  • 13.2.4 Celgene Revenue in Anticancer Drug Business (2015-2020)
  • 13.2.5 Celgene Recent Development
• 13.3 Pfizer
  • 13.3.1 Pfizer Company Details
  • 13.3.2 Pfizer Business Overview
  • 13.3.3 Pfizer Anticancer Drug Introduction
  • 13.3.4 Pfizer Revenue in Anticancer Drug Business (2015-2020)
  • 13.3.5 Pfizer Recent Development
• 13.4 Bristol-Myers Squibb
  • 13.4.1 Bristol-Myers Squibb Company Details
  • 13.4.2 Bristol-Myers Squibb Business Overview
  • 13.4.3 Bristol-Myers Squibb Anticancer Drug Introduction
  • 13.4.4 Bristol-Myers Squibb Revenue in Anticancer Drug Business (2015-2020)
  • 13.4.5 Bristol-Myers Squibb Recent Development
• 13.5 Novartis
  • 13.5.1 Novartis Company Details
  • 13.5.2 Novartis Business Overview
  • 13.5.3 Novartis Anticancer Drug Introduction
  • 13.5.4 Novartis Revenue in Anticancer Drug Business (2015-2020)
  • 13.5.5 Novartis Recent Development
• 13.6 AstraZeneca
  • 13.6.1 AstraZeneca Company Details
  • 13.6.2 AstraZeneca Business Overview
  • 13.6.3 AstraZeneca Anticancer Drug Introduction
  • 13.6.4 AstraZeneca Revenue in Anticancer Drug Business (2015-2020)
  • 13.6.5 AstraZeneca Recent Development
• 13.7 Teva Pharmaceuticals
  • 13.7.1 Teva Pharmaceuticals Company Details
  • 13.7.2 Teva Pharmaceuticals Business Overview
  • 13.7.3 Teva Pharmaceuticals Anticancer Drug Introduction
  • 13.7.4 Teva Pharmaceuticals Revenue in Anticancer Drug Business (2015-2020)
  • 13.7.5 Teva Pharmaceuticals Recent Development
• 13.8 Bayer
  • 13.8.1 Bayer Company Details
  • 13.8.2 Bayer Business Overview
  • 13.8.3 Bayer Anticancer Drug Introduction
  • 13.8.4 Bayer Revenue in Anticancer Drug Business (2015-2020)
  • 13.8.5 Bayer Recent Development
• 13.9 GlaxoSmithKline
  • 13.9.1 GlaxoSmithKline Company Details
  • 13.9.2 GlaxoSmithKline Business Overview
  • 13.9.3 GlaxoSmithKline Anticancer Drug Introduction
  • 13.9.4 GlaxoSmithKline Revenue in Anticancer Drug Business (2015-2020)
  • 13.9.5 GlaxoSmithKline Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer